GenoSpace, a Cambridge, Mass.-based informatics startup, has launched a cloud-based platform intended to provide access to a variety of 'omic and phenotype data.

The company, which opened its doors in 2011, has taken advantage, or "lessons" learned, from compute infrastructure development efforts at the Dana-Farber Cancer Institute focused on linking clinical and genomic information, John Quackenbush, a professor of computational biology and bioinformatics at Dana-Farber and GenoSpace's CEO, told BioInform in an interview last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.